Phase 2, Open-label Study to Evaluate CC-10004 Recalcitrant (Not Responded to Therapy) Plaque-type Psoriasis

This study has been completed.

Study NCT00521339 Information provided by Celgene Corporation

First Received: August 24, 2007 Last Updated: September 28, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2009
Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)